{
  "completed_form": {
    "Precertification Request Details": {
      "Request Type": "Start of treatment",
      "Start date": "2024-05-22",
      "Date of last treatment": null,
      "Precertification Requested By Name": "Erfan Rostami",
      "Precertification Requested By Phone": "615-343-1176",
      "Precertification Requested By Fax": "615-343-1219"
    },
    "A. PATIENT INFORMATION": {
      "First Name": "Shakh",
      "Last Name": "Abdulla",
      "DOB": "2001-04-01",
      "Address": "425 Sherman Aves AP'T D",
      "City": "Nashville",
      "State": "TN",
      "ZIP": "37995",
      "Home Phone": "865-395-3958",
      "Work Phone": null,
      "Cell Phone": "865-395-0481",
      "E-mail": null,
      "Current Weight": null,
      "Height": null,
      "Allergies": "No Known Allergies"
    },
    "B. INSURANCE INFORMATION": {
      "Member ID #": "LAJM14345116",
      "Does patient have other coverage?": false,
      "Group #": "435000",
      "Other Coverage ID #": null,
      "Other Carrier Name": null,
      "Insured 1": null,
      "Insured 2": null,
      "Insured 3": null
    },
    "C. PRESCHIBER INFORMATION": {
      "First Name": "Hao",
      "Last Name": "Gu",
      "Prescriber Type": "M.D.",
      "Address": "3320 Montgomery Dr",
      "City": "NASHVILLE",
      "State": "TN",
      "ZIP": "37361",
      "Phone": "614-936-0065",
      "Fax": "615-562-4820",
      "St Lic #": null,
      "NPI #": "1154611523",
      "DEA #": null,
      "UPIN": null,
      "Provider Email": null,
      "Office Contact Name": "Erfan Rostami",
      "Office Contact Phone": "615-343-1176"
    },
    "D. DISPENSING PROVIDER/ADMINISTRATION INFORMATION": {
      "Place of Administration": "Outpatient Infusion Center",
      "Agency Name": null,
      "Administration code(s) (CPT)": null,
      "Dispensing Provider/Pharmacy Type": "Other",
      "Dispensing Provider/Pharmacy Name": "Peds Infusion (Leantaas)",
      "Dispensing Provider/Pharmacy Phone 1": "615-936-1762",
      "Dispensing Provider/Pharmacy Address": "2211 Broad Way, Tower 4th FL, Suite 6102",
      "Dispensing Provider/Pharmacy City": "Nashville",
      "Dispensing Provider/Pharmacy State": "TN",
      "Dispensing Provider/Pharmacy ZIP": "37232",
      "Dispensing Provider/Pharmacy Phone 2": null,
      "Dispensing Provider/Pharmacy Fax 1": null,
      "Dispensing Provider/Pharmacy Fax 2": null,
      "Dispensing Provider/Pharmacy TIN": null,
      "Dispensing Provider/Pharmacy PIN": null,
      "Dispensing Provider/Pharmacy NPI 1": null,
      "Dispensing Provider/Pharmacy NPI 2": null,
      "Dispensing Provider/Pharmacy Other Type Specify": "Infusion Center"
    },
    "E. PRODUCT INFORMATION": {
      "Request is for": "Truxima (rituximab-abbs)",
      "Dose": "694 mg",
      "Directions for Use": "Initial dose: 694 mg, intraVENOUS, once, every 2 weeks. Maintenance dose: 694 mg, intraVENOUS, once, every 24 weeks.",
      "HCPCS Code": null
    },
    "F. DIAGNOSIS INFORMATION": {
      "Primary ICD Code": "G35",
      "Other ICD Code": null
    },
    "G. CLINICAL INFORMATION": {
      "Has the patient had prior therapy with the requested product within the last 365 days?": false,
      "Has the patient had a trial and failure of any of the following rituximab biosimilars?": false,
      "Trial and failure biosimilars (rituximab biosimilars)": null,
      "When was the member's trial and failure of the preferred drug (rituximab biosimilars)?": null,
      "Describe the nature of the failure of the preferred drug (rituximab biosimilars)": null,
      "Has the patient had an adverse reaction to any of the following rituximab biosimilars?": false,
      "Adverse reaction biosimilars (rituximab biosimilars)": null,
      "When was the member's adverse reaction to the preferred drug (rituximab biosimilars)?": null,
      "Describe the nature of the adverse reaction to the preferred drug (rituximab biosimilars)": null,
      "Explain contraindications/medical reasons patient cannot use Ruxience/Truxima": null,
      "Has the patient had a trial and failure of Inflectra, Renflexis, Simponi Aria?": false,
      "Trial and failure products (Inflectra, Renflexis, Simponi Aria)": null,
      "When was the member's trial and failure of preferred drug (Inflectra, Renflexis, Simponi Aria)?": null,
      "Describe the nature of the failure of preferred drug (Inflectra, Renflexis, Simponi Aria)": null,
      "Has the patient had an adverse reaction to Inflectra, Renflexis, Simponi Aria?": false,
      "Adverse reaction products (Inflectra, Renflexis, Simponi Aria)": null,
      "When was the member's adverse reaction to preferred drug (Inflectra, Renflexis, Simponi Aria)?": null,
      "Describe the nature of the adverse reaction to preferred drug (Inflectra, Renflexis, Simponi Aria)": null,
      "Explain contraindications/medical reasons patient cannot use Inflectra, Renflexis, Simponi Aria": null,
      "Explain contraindications/medical reasons patient cannot use Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR": null,
      "Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs?": null,
      "Acute lymphoid leukemia: Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?": false,
      "Acute lymphoid leukemia: Is Rituxan (rituximab) being used as induction/consolidation therapy?": null,
      "Autoimmune hemolytic anemia: Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia?": false,
      "ANCA-associated vasculitides type": null,
      "ANCA-associated vasculitides: Will Rituxan (rituximab) be given in conjunction with glucocorticoids?": null,
      "Autoimmune blistering diseases, corticosteroid-refractory: Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?": false,
      "Autoimmune blistering disease type": null,
      "B-cell lymphoma type": null,
      "B-cell lymphoma Other Specify": null,
      "Castleman's disease: Does the patient have a documented diagnosis of multicentric Castleman's disease (angiofollicular lymph node hyperplasia)?": false,
      "Central nervous system lymphomas type": null,
      "Chronic or small lymphocytic leukemia type": null,
      "Cryoglobulinemia: Does the patient have a documented diagnosis of cryoglobulinemia?": false,
      "Cryoglobulinemia: Is there clinical documentation that the treatment with corticosteroids and other immunosuppressive agents was ineffective?": null,
      "Graft versus host disease, chronic: Is there a documentation that Rituxan (rituximab) is being used as last-resort treatment for chronic graft versus host disease (GVHD)?": false,
      "Hairy cell leukemia type": null,
      "Heart and solid organ transplant: Is there documentation that Rituxan (rituximab) is being used for treatment or prevention of highly sensitized patients with antibody mediated rejection in heart/solid organ transplant recipients?": false,
      "Transplant recipient type": null,
      "Immune checkpoint-inhibitor caused encephalitis": null,
      "Immune checkpoint-inhibitor caused encephalitis Other Specify": null,
      "Rheumatoid Arthritis: Severity of the patient's rheumatoid arthritis": null,
      "Rheumatoid Arthritis: Is there evidence that the disease is active?": null,
      "Rheumatoid Arthritis: Will Rituxan (rituximab) be used in combination with methotrexate?": null,
      "Rheumatoid Arthritis: Was treatment with methotrexate ineffective, not tolerated or contraindicated?": null,
      "Rheumatoid Arthritis: Methotrexate treatment reason for failure": null,
      "Rheumatoid Arthritis: Was treatment with another conventional DMARD ineffective?": null,
      "Rheumatoid Arthritis: Ineffective conventional DMARDs": null,
      "Sj\u00f6gren syndrome: Does the patient have a documented diagnosis of Sj\u00f6gren's syndrome?": false,
      "Sj\u00f6gren syndrome: Was treatment with corticosteroids and other immunosuppressive agents ineffective?": null,
      "Sj\u00f6gren syndrome: Medication 1 for ineffective corticosteroids and other immunosuppressive agents": null,
      "Sj\u00f6gren syndrome: Dates 1 for ineffective corticosteroids and other immunosuppressive agents": null,
      "Sj\u00f6gren syndrome: Medication 2 for ineffective corticosteroids and other immunosuppressive agents": null,
      "Sj\u00f6gren syndrome: Dates 2 for ineffective corticosteroids and other immunosuppressive agents": null,
      "Thrombotic thrombocytopenic purpura: Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?": false,
      "Waldenstrom's macroglobulinemia: Does the patient have a documented diagnosis of Waldenstr\u00f6m macroglobulinemia?": false,
      "Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)?": null,
      "Length of time on Rituxan (rituximab)": null
    }
  },
  "processing_notes": [
    {
      "field": "Date of last treatment",
      "note": "Dependent field's condition ('Request Type' = 'Continuation of therapy') was not met."
    },
    {
      "field": "Work Phone",
      "note": "Information not found in source text."
    },
    {
      "field": "E-mail",
      "note": "Information not found in source text."
    },
    {
      "field": "Current Weight",
      "note": "Information not found in source text."
    },
    {
      "field": "Height",
      "note": "Information not found in source text."
    },
    {
      "field": "Other Coverage ID #",
      "note": "Dependent field's condition ('Does patient have other coverage?' = 'true') was not met."
    },
    {
      "field": "Other Carrier Name",
      "note": "Dependent field's condition ('Does patient have other coverage?' = 'true') was not met."
    },
    {
      "field": "Insured 1",
      "note": "Information not found in source text."
    },
    {
      "field": "Insured 2",
      "note": "Information not found in source text."
    },
    {
      "field": "Insured 3",
      "note": "Information not found in source text."
    },
    {
      "field": "St Lic #",
      "note": "Information not found in source text."
    },
    {
      "field": "DEA #",
      "note": "Information not found in source text."
    },
    {
      "field": "UPIN",
      "note": "Information not found in source text."
    },
    {
      "field": "Provider Email",
      "note": "Information not found in source text."
    },
    {
      "field": "Agency Name",
      "note": "Dependent field's condition ('Place of Administration' = 'Home Infusion Center') was not met."
    },
    {
      "field": "Administration code(s) (CPT)",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy Phone 2",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy Fax 1",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy Fax 2",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy TIN",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy PIN",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy NPI 1",
      "note": "Information not found in source text."
    },
    {
      "field": "Dispensing Provider/Pharmacy NPI 2",
      "note": "Information not found in source text."
    },
    {
      "field": "HCPCS Code",
      "note": "Information not found in source text."
    },
    {
      "field": "Other ICD Code",
      "note": "Information not found in source text."
    },
    {
      "field": "Trial and failure biosimilars (rituximab biosimilars)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "When was the member's trial and failure of the preferred drug (rituximab biosimilars)?",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "Describe the nature of the failure of the preferred drug (rituximab biosimilars)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "Adverse reaction biosimilars (rituximab biosimilars)",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "When was the member's adverse reaction to the preferred drug (rituximab biosimilars)?",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "Describe the nature of the adverse reaction to the preferred drug (rituximab biosimilars)",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to any of the following rituximab biosimilars?' = 'true') was not met."
    },
    {
      "field": "Explain contraindications/medical reasons patient cannot use Ruxience/Truxima",
      "note": "Information not found in source text."
    },
    {
      "field": "Trial and failure products (Inflectra, Renflexis, Simponi Aria)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of Inflectra, Renflexis, Simponi Aria?' = 'true') was not met."
    },
    {
      "field": "When was the member's trial and failure of preferred drug (Inflectra, Renflexis, Simponi Aria)?",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of Inflectra, Renflexis, Simponi Aria?' = 'true') was not met."
    },
    {
      "field": "Describe the nature of the failure of preferred drug (Inflectra, Renflexis, Simponi Aria)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of Inflectra, Renflexis, Simponi Aria?' = 'true') was not met."
    },
    {
      "field": "Adverse reaction products (Inflectra, Renflexis, Simponi Aria)",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to Inflectra, Renflexis, Simponi Aria?' = 'true') was not met."
    },
    {
      "field": "When was the member's adverse reaction to preferred drug (Inflectra, Renflexis, Simponi Aria)?",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to Inflectra, Renflexis, Simponi Aria?' = 'true') was not met."
    },
    {
      "field": "Describe the nature of the adverse reaction to preferred drug (Inflectra, Renflexis, Simponi Aria)",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to Inflectra, Renflexis, Simponi Aria?' = 'true') was not met."
    },
    {
      "field": "Trial and failure products (Enbrel, Humira, etc.)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR?' = 'true') was not met."
    },
    {
      "field": "When was the member's trial and failure of preferred drug (Enbrel, Humira, etc.)?",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR?' = 'true') was not met."
    },
    {
      "field": "Describe the nature of the failure of preferred drug (Enbrel, Humira, etc.)",
      "note": "Dependent field's condition ('Has the patient had a trial and failure of Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR?' = 'true') was not met."
    },
    {
      "field": "Adverse reaction products (Enbrel, Humira, etc.)",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR?' = 'true') was not met."
    },
    {
      "field": "When was the member's adverse reaction to preferred drug (Enbrel, Humira, etc.)?",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR?' = 'true') was not met."
    },
    {
      "field": "Describe the nature of the adverse reaction to preferred drug (Enbrel, Humira, etc.)",
      "note": "Dependent field's condition ('Has the patient had an adverse reaction to Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR?' = 'true') was not met."
    },
    {
      "field": "Explain contraindications/medical reasons patient cannot use Inflectra, Renflexis, Simponi Aria",
      "note": "Information not found in source text."
    },
    {
      "field": "Explain contraindications/medical reasons patient cannot use Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR",
      "note": "Information not found in source text."
    },
    {
      "field": "Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs?",
      "note": "Information not found in source text."
    },
    {
      "field": "Acute lymphoid leukemia: Is Rituxan (rituximab) being used as induction/consolidation therapy?",
      "note": "Dependent field's condition ('Acute lymphoid leukemia: Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?' = 'true') was not met."
    },
    {
      "field": "ANCA-associated vasculitides type",
      "note": "Information not found in source text."
    },
    {
      "field": "ANCA-associated vasculitides: Will Rituxan (rituximab) be given in conjunction with glucocorticoids?",
      "note": "Information not found in source text."
    },
    {
      "field": "Autoimmune blistering disease type",
      "note": "Dependent field's condition ('Autoimmune blistering diseases, corticosteroid-refractory: Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?' = 'true') was not met."
    },
    {
      "field": "B-cell lymphoma type",
      "note": "Information not found in source text."
    },
    {
      "field": "B-cell lymphoma Other Specify",
      "note": "Dependent field's condition ('B-cell lymphoma type' = 'Other') was not met."
    },
    {
      "field": "Central nervous system lymphomas type",
      "note": "Information not found in source text."
    },
    {
      "field": "Chronic or small lymphocytic leukemia type",
      "note": "Information not found in source text."
    },
    {
      "field": "Cryoglobulinemia: Is there clinical documentation that the treatment with corticosteroids and other immunosuppressive agents was ineffective?",
      "note": "Dependent field's condition ('Cryoglobulinemia: Does the patient have a documented diagnosis of cryoglobulinemia?' = 'true') was not met."
    },
    {
      "field": "Hairy cell leukemia type",
      "note": "Information not found in source text."
    },
    {
      "field": "Transplant recipient type",
      "note": "Dependent field's condition ('Heart and solid organ transplant: Is there documentation that Rituxan (rituximab) is being used for treatment or prevention of highly sensitized patients with antibody mediated rejection in heart/solid organ transplant recipients?' = 'true') was not met."
    },
    {
      "field": "Immune checkpoint-inhibitor caused encephalitis",
      "note": "Information not found in source text."
    },
    {
      "field": "Immune checkpoint-inhibitor caused encephalitis Other Specify",
      "note": "Dependent field's condition ('Immune checkpoint-inhibitor caused encephalitis' = 'Other') was not met."
    },
    {
      "field": "Rheumatoid Arthritis: Severity of the patient's rheumatoid arthritis",
      "note": "Information not found in source text."
    },
    {
      "field": "Rheumatoid Arthritis: Is there evidence that the disease is active?",
      "note": "Information not found in source text."
    },
    {
      "field": "Rheumatoid Arthritis: Will Rituxan (rituximab) be used in combination with methotrexate?",
      "note": "Information not found in source text."
    },
    {
      "field": "Rheumatoid Arthritis: Was treatment with methotrexate ineffective, not tolerated or contraindicated?",
      "note": "Dependent field's condition ('Rheumatoid Arthritis: Will Rituxan (rituximab) be used in combination with methotrexate?' = 'true') was not met."
    },
    {
      "field": "Rheumatoid Arthritis: Methotrexate treatment reason for failure",
      "note": "Dependent field's condition ('Rheumatoid Arthritis: Was treatment with methotrexate ineffective, not tolerated or contraindicated?' = 'true') was not met."
    },
    {
      "field": "Rheumatoid Arthritis: Was treatment with another conventional DMARD ineffective?",
      "note": "Information not found in source text."
    },
    {
      "field": "Rheumatoid Arthritis: Ineffective conventional DMARDs",
      "note": "Dependent field's condition ('Rheumatoid Arthritis: Was treatment with another conventional DMARD ineffective?' = 'true') was not met."
    },
    {
      "field": "Sj\u00f6gren syndrome: Was treatment with corticosteroids and other immunosuppressive agents ineffective?",
      "note": "Dependent field's condition ('Sj\u00f6gren syndrome: Does the patient have a documented diagnosis of Sj\u00f6gren's syndrome?' = 'true') was not met."
    },
    {
      "field": "Sj\u00f6gren syndrome: Medication 1 for ineffective corticosteroids and other immunosuppressive agents",
      "note": "Dependent field's condition ('Sj\u00f6gren syndrome: Was treatment with corticosteroids and other immunosuppressive agents ineffective?' = 'true') was not met."
    },
    {
      "field": "Sj\u00f6gren syndrome: Dates 1 for ineffective corticosteroids and other immunosuppressive agents",
      "note": "Dependent field's condition ('Sj\u00f6gren syndrome: Was treatment with corticosteroids and other immunosuppressive agents ineffective?' = 'true') was not met."
    },
    {
      "field": "Sj\u00f6gren syndrome: Medication 2 for ineffective corticosteroids and other immunosuppressive agents",
      "note": "Dependent field's condition ('Sj\u00f6gren syndrome: Was treatment with corticosteroids and other immunosuppressive agents ineffective?' = 'true') was not met."
    },
    {
      "field": "Sj\u00f6gren syndrome: Dates 2 for ineffective corticosteroids and other immunosuppressive agents",
      "note": "Dependent field's condition ('Sj\u00f6gren syndrome: Was treatment with corticosteroids and other immunosuppressive agents ineffective?' = 'true') was not met."
    },
    {
      "field": "Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)?",
      "note": "Dependent field's condition ('Request Type' = 'Continuation of therapy') was not met."
    },
    {
      "field": "Length of time on Rituxan (rituximab)",
      "note": "Dependent field's condition ('Request Type' = 'Continuation of therapy') was not met."
    }
  ]
}